AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (4.6 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access | Just Accepted

Piper nigrum L. and its main component piperine ameliorate hyperuricemia and hyperuricemia-related renal inflammation through suppressing the JAK2-STAT3-XDH/SOCS3/TNF-α signalling pathway

Nan-Chuan Li1,Mei-Ling Xin2,Xin-Hua Song2Hong-Yu Wang2Fu-Yuan Yang3Jing-Da Li1( )Wen-Long Sun2( )

1 College of Life Science, Yangtze University, Jingzhou 434000, China.

2 School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255000, China.

3 School of Basic Medicine, Yangtze University Health Science Center, Jingzhou 434000, China.

Nan-Chuan Li and Mei-Ling Xin contributed equally to this work.

Show Author Information

Abstract

Hyperuricemia is a metabolic disease characterized by serum uric acid (UA) levels remaining above normal levels for a long period of time, which has become a huge challenge faced by society. The fruits of P. nigrum L (P. nigrum) as traditional Indian medicine was used to treat various diseases. However, the anti-hyperuricemia effect and mechanism of the ethanol extract of P. nigrum (PE) and its primary component, piperine (PI) still need to be elaborated. In this study, we systematically evaluated the effects of PE and PI on hyperuricemia, as well as their underlying mechanisms in the hyperuricemic mouse and cell models. Our results showed that PE effectively prevented abnormal elevation of UA level, and restored renal function in hyperuricemic mouse model. Transcriptomic and western blot analysis revealed that PE respectively relieved hepatic synthesis of UA and enhanced renal excretion of UA through suppressing the expressions of xanthine dehydrogenase (XDH) and glucose transporter member 9 (GLUT9) in vitro and in vivo. Additionally, PE ameliorated renal inflammation by reducing the expressions of suppressor of cytokine signalling 3 (SOCS3) and TNF-α. Furthermore, the experimental results for PI were consistent with those observed for PE. Mechanistically, the gene overexpression of JAK2, luciferase reporter gene and molecular docking results demonstrated that the anti-hyperuricemia effect of PE was associated with the blocking of the Janus Kinase 2/ Signal transducers and activators of transcription (JAK2/STAT3) signalling transduction, and PI could specifically bound to JAK2. These data suggested that PE could ameliorate hyperuricemia and hyperuricemia-related renal inflammation through suppressing the JAK2-STAT3-XDH/SOCS3/TNF-α signalling pathway, and  the beneficial effects of PE presumably were attributed to PI. In summary, our study suggests that PE may be an effective natural product for improving hyperuricemia by restoring the metabolic balance of UA and suppressing renal inflammation.

References

【1】
【1】
 
 
Food & Medicine Homology

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Li N-C, Xin M-L, Song X-H, et al. Piper nigrum L. and its main component piperine ameliorate hyperuricemia and hyperuricemia-related renal inflammation through suppressing the JAK2-STAT3-XDH/SOCS3/TNF-α signalling pathway. Food & Medicine Homology, 2026, https://doi.org/10.26599/FMH.2027.9420159

325

Views

69

Downloads

0

Crossref

0

Web of Science

Received: 15 January 2025
Revised: 11 September 2025
Accepted: 18 September 2025
Available online: 30 June 2026

© National R & D Center for Edible Fungus Processing Technology 2026. Published by Tsinghua University Press.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).